Vaccines Xagena

Xagena Mappa
Medical Meeting
Xagena Salute

Search results for "9-valent HPV Vaccine"

Merck & Co has announced that in the pivotal phase III efficacy study, its investigational 9-valent HPV vaccine ( V503 ) prevented approximately 97% of cervical, vaginal and vulvar pre-cancers cau ...

Human papillomavirus ( HPV ) causes nearly all cervical cancers and some cancers of the vagina, vulva, penis, anus, and oropharynx. Most HPV infections are asymptomatic and clear spontaneously within ...